Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

NO_LONGER_AVAILABLE

Conditions studied: Diabetes Mellitus, Type 1

In brief

The purpose of this protocol is to provide continued acess to immunosuppressive medications to subjects from the completed/closed trial ITN005CT (NIS01,NCT00014911). THIS PROTOCOL DOES NOT PROVIDE MEDICINES TO DIABETES PATIENTS WHO DID NOT PARTICIPATE IN ITN005CT.

Key facts

Study ID
NCT01309022
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
Last updated by the study team
2016-02-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.